Medindia

X

Canadian Court Upholds Pfizer's Patent for Viagra

by VR Sreeraman on  June 19, 2009 at 5:33 PM Drug News   - G J E 4
A Canadian federal court on Thursday upheld pharmaceutical giant Pfizer's patent for Viagra, dashing generic drug maker Novopharm's longing for sales of cheaper erection drugs.

Judge Michael Kelen said in his decision that Novopharm failed to demonstrate the Pfizer patent was invalid.
 Canadian Court Upholds Pfizer's Patent for Viagra
Canadian Court Upholds Pfizer's Patent for Viagra
Advertisement

He ordered Canada's health minister not to grant the generic drug maker's request for special permission to manufacture a Viagra knock-off until the Pfizer patent expires in 2014.

Pfizer had filed the application to prohibit Novopharm from introducing a generic version of the hugely popular drug.

Sildenafil, the key ingredient in Viagra, was initially developed by Pfizer in the mid-1980s as one of a number of compounds for the treatment of hypertension and angina.

Angina patients unexpectedly experienced erections while being treated with sildenafil to lower their blood pressure, and so it was marketed to treat erectile dysfunction.

In its submissions, Novopharm, a subsidiary of the world's largest generic drug-maker Teva Pharmaceutical, questioned the timing of patent filings around Pfizer's discovery of the active ingredient in Viagra.

But in his decision, Judge Kelen said: "The court concludes that the applicants have met their legal burden to establish the validity of the patent."

Source: AFP
LIN

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
Advertisement

More News on: